Discovery and biological characterization of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight
Highlights
► Sunlight has an important role in generating bioactive molecules that can activate the AHR. ► Identification of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole (IPI) as a new AHR-inducing tryptophan (TRP) photoproduct. ► IPI induces AHR-mediated P450 activity (EROD) and suppresses glucose output. ► IPI, a prominent component of photoactivated TRP, induces EROD additively with FICZ or TCDD. ► IPI was detected in tissue culture medium in ordinary ambient light conditions.
Introduction
The environmental toxin and industrial by-product TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, dioxin) is the most potent and best studied activator of the aryl hydrocarbon receptor (AHR), a ligand activated transcription factor and member of the Per-Arnt-Sim (PAS) protein family [1], [2]. Activation of the AHR by TCDD elicits diverse pathological effects, including tumor promotion and metabolic dysregulation leading to a wasting syndrome [1], [2], [3].
Ligand activation causes the AHR to migrate from cytosol to the nucleus and form a complex with the aryl hydrocarbon nuclear translocator (ARNT) that can bind dioxin-responsive elements (DREs) in the promoter regions of target genes including xenobiotic-metabolizing cytochrome P450 (CYP1A) enzymes and TCDD-inducible poly [ADP-ribose] polymerase (TiPARP, PARP7) [4]. In addition to environmental toxins like TCDD, some natural products have recently been shown to activate the AHR, among which tryptophan (TRP) derivatives comprise a large group [5]. These include TRP derivatives ingested in the diet or produced by metabolism in vivo, such as indolo[3,2-b]carbazole (ICZ) [6], and photoproducts formed by exposure of TRP to UV or visible light [7], [8], [9], among which 6-formylindolo[3,2-b]carbazole (FICZ) is the best characterized [10]. The discovery of natural compounds that can bind and activate the AHR has stimulated a search for diverse AHR ligands that may elicit pathologic effects (e.g., tumorigenesis, metabolic dysregulation) or as yet unrecognized physiologic activities of the AHR.
We previously reported that exposure of an aqueous solution of TRP to sunlight passing through window glass (aTRP) produces multiple photoproducts capable of activating the AHR and inducing CYP1A-mediated enzyme activities, including arachidonic acid epoxygenation and 7-ethoxyresorufin deethylation (EROD) [8]. FICZ was identified in one of 14 fractions obtained by separation of aTRP by reverse phase high pressure liquid chromatograph (RP-HPLC), all of which exhibited CYP1A inducing capacity. That prior study showed that photoactivated TRP contains many AHR inducers in addition to FICZ. We report here the identification, chemical characterization and synthesis of a novel photoproduct present in aTRP that induces CYP1A with high efficacy: 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole (IPI).
Section snippets
Materials
Chemicals were from Sigma–Aldrich, (St. Louis, MO), TCI (Portland, OR) or Alfa Aesar (Ward Hill, MA) and were used without further purification. Tissue culture medium and additives were from GIBCO BRL Life Technologies (Gaithersburg, MD). HPLC chemicals were of HPLC or LC/MS grade. Fertilized White Leghorn chicken eggs were obtained from Burr Farm (Hampton, CT), TCDD was from the NCI Chemical Carcinogen Repository, (Kansas City, MO) and FICZ was from Biomol/Enzo Life Sciences (Plymouth Meeting,
Isolation of the main EROD inducing peaks in fraction 7 of 14 fractions collected from RP-HPLC separation of an aTRP solution exposed to sunlight for 7 days
We previously reported [8] the separation by HPLC of 14 UV-absorbing fractions in a solution of activated tryptophan (aTRP) after a 7-day exposure to sunlight and found that all of the fractions induced EROD activity to varying extents (Fig. 1A). Since fraction 7 (F7) produced substantial EROD induction with fewer UV absorbing peaks than prior eluting fractions, it seemed likely to contain a prominent and effective EROD inducer. Therefore, we set out to identify the main EROD-inducing molecular
Discussion
We report here the discovery of a novel TRP photoproduct with AHR-inducing properties generated by exposure of an aqueous solution of TRP to sunlight passing through window glass. The compound was purified from a mixture of photoproducts, the chemical formula was assigned by accurate mass measurement and a putative structure 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole (to which we have assigned the acronym “IPI”), was proposed on the basis of extensive MS/MS and pseudo MS3 analyses. IPI was
Conflict of interest statement
None declared.
Acknowledgments
This work was supported by NIH Grants ES03606 (ABR), HL87062 (SSG) and RR27305 (SSG), and by a grant from the Winston Foundation (ABR). TCDD was provided by the National Cancer Institute’s Chemical Carcinogen Reference Standards Repository operated under contract by Midwest Research Institute, Kansas City, MO, NO2-CB-666000. We thank Dr. Ivan Haller for his helpful input and discussions during the initial phase of this work.
References (33)
- et al.
Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect
J. Biol. Chem.
(2010) - et al.
Regulation of CYP1A1 by indolo[3,2-b]carbazole in murine hepatoma cells
J. Biol. Chem.
(1995) - et al.
Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole
Chem. Biol. Interact.
(1998) - et al.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
Methods
(2001) - et al.
Calculating slope and ED50 of additive dose–response curves and application of these tabulated parameter values
J. Pharmacol. Toxicol. Methods
(1995) - et al.
An iminophosphorane-mediated efficeint synthesis of the alkaloid Eudistomin U of marine origin
Tetrahedron Lett.
(1995) - et al.
New syntheses of the marine alkaloids eudistomins D and U
Tetrahedron Lett.
(1995) - et al.
Beta-naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase
J. Biol. Chem.
(1992) - et al.
Half-lives of tetra-, penta-, hexa-, hepta-, and octachlorodibenzo-p-dioxin in rats, monkeys, and humans – a critical review
Chemosphere
(2002) - et al.
The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors
FEBS Lett.
(2007)
AhR ligands, malassezin and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis
J. Invest. Dermatol.
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Biol. Chem.
Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli
Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.
2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity
Annu. Rev. Pharmacol. Toxicol.
Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals
Annu. Rev. Pharmacol. Toxicol.
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation
Proc. Natl. Acad. Sci. USA
Cited by (18)
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
2018, ImmunityCitation Excerpt :Finally, exposure of Trp to ultraviolet light triggers its photo-oxidation to 6-formylindolo[3,2-b]carbazole (FICZ), a potent AhR ligand (Rannug et al., 1987; Wincent et al., 2009), with broad implications in UV light response, genomic stability, circadian rhythms, and the immune response (Quintana et al., 2008; Veldhoen et al., 2008; Wincent et al., 2012). Additional Trp photometabolites exist, such as 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole, which exhibits a potency similar to that of FICZ (Diani-Moore et al., 2011). These photometabolites may have both local effects in the skin and also systemic effects because FICZ has been detected in human urine (Wincent et al., 2012).
Time-dependent transcriptomic and biochemical responses of 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are explained by AHR activation time
2016, Biochemical PharmacologyCitation Excerpt :Interestingly, the LC50 (95% CI) value estimated for FICZ in CEH [14,000 nM (12,000–16,000 nM)] was approximately similar to the LC50 (95% CI) value in COS-7 cells [9400 nM (4700–19,000 nM)] [11]. FICZ was shown to be readily metabolized by cultured hepatocytes [56,8], while the results of our previous study demonstrated that COS-7 cells express no or very low levels of CYP1A to metabolize FICZ [11]. Thus, an approximately equal sensitivity of CEH and COS-7 cells to FICZ suggests that the ability of CEH to rapidly metabolize FICZ does not significantly increase their tolerance to FICZ toxicity.
Sensitivity of avian species to the aryl hydrocarbon receptor ligand 6-formylindolo [3,2-b] carbazole (FICZ)
2014, Chemico-Biological InteractionsCitation Excerpt :Approximately equal EC50 and ReP values for FICZ were observed at different time-points in COS-7 cells transfected with chicken AHR1 construct (Table 3). However, previous studies showed that the EC50 and ReP values for FICZ were changed dramatically over time in other cell types because FICZ was extensively metabolized [7,20,23,41]. Our findings suggest that such metabolism of FICZ in COS-7 cells does not occur.
Aryl hydrocarbon receptor activation by dioxin targets phosphoenolpyruvate carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD)-inducible poly(ADP-ribose) polymerase (TiPARP)
2013, Journal of Biological ChemistryCitation Excerpt :Second, it seems likely that AHR effects on ADP-ribosylation shown here will have implications beyond TCDD toxicity. There is increasing interest in biologic effects of natural AHR ligands present in food, in the environment, or generated in the body (59–62) and in AHR effects on physiologic processes, most conspicuously, immune and gastrointestinal system function (63–65). In fact, a role for TiPARP in TCDD modification of immune system function has been suggested (66).
Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet
2012, Pharmacological ResearchCitation Excerpt :On the other hand, the decreased plasma tryptophan level may additionally affect cytochrome P450 expression in a more direct way (not only via the nervous system). It has been shown that tryptophan or its indole derivatives increase hepatic protein synthesis, cytochrome P450 content, and the enzyme activity of rats and other species in vitro and in vivo [46–51]. Moreover, tryptophan is an amino acid which is essential for the synthesis of cytochrome P450.
FICZ, a Tryptophan photoproduct, suppresses pulmonary eosinophilia and Th2-type cytokine production in a mouse model of ovalbumin-induced allergic asthma
2012, International ImmunopharmacologyCitation Excerpt :In addition, UVB exposure of human skin induced CYP1A1 and CYP1B1 expression, raising a possibility that tryptophan photoproducts including FICZ are involved in AhR activation [43]. The rate of conversion from tryptophan to FICZ is about 0.0001% in cells and ex vitro [40,44] and the turnover rate is high with a decrease by 81% after 24 h of incubation [44]. At present, it remains to be seen how much of FICZ is produced in the skin exposed to UV and how relevant the results in this study is to asthma incidence in humans, because of differences in tryptophan metabolism among mammalian species [45,46].
- 1
Present address: Genetica DNA Laboratories, Inc., 8740 Montgomery Road, Cincinnati, OH 45236, USA.
- 2
Present address: Analytical Pharmacology Laboratory, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.